---
figid: PMC8069739__pharmaceutics-13-00520-g004
figtitle: Schematic to explain breast cancer immunotherapy by codelivery of an immunogenic
  cell death stimulus plus an inhibitor of the IDO-1 pathway
organisms:
- NA
pmcid: PMC8069739
filename: pharmaceutics-13-00520-g004.jpg
figlink: pmc/articles/PMC8069739/figure/pharmaceutics-13-00520-f004/
number: F4
caption: Schematic to explain breast cancer immunotherapy by codelivery of an immunogenic
  cell death stimulus plus an inhibitor of the IDO-1 pathway. Adapted with permission
  from [], ACS Nano 2018. https://pubs.acs.org/doi/full/10.1021/acsnano.8b05189 22
  February 2021. CRT, calreticulin; BC, breast cancer; HMGB-1, high mobility group
  box 1 protein.
papertitle: Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy.
reftext: Tianqi Wang, et al. Pharmaceutics. 2021 Apr;13(4):520.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9486319
figid_alias: PMC8069739__F4
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC8069739__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8069739__pharmaceutics-13-00520-g004.html
  '@type': Dataset
  description: Schematic to explain breast cancer immunotherapy by codelivery of an
    immunogenic cell death stimulus plus an inhibitor of the IDO-1 pathway. Adapted
    with permission from [], ACS Nano 2018. https://pubs.acs.org/doi/full/10.1021/acsnano.8b05189
    22 February 2021. CRT, calreticulin; BC, breast cancer; HMGB-1, high mobility
    group box 1 protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - dc
  - Dsp1
  - ATPsynbeta
  - Atpalpha
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Me
  - crt
  - Calr
  - Doxorubicin
  - ATP
  - tumor
  - metastases
  - Cytotoxic
---
